Provided by Tiger Trade Technology Pte. Ltd.

Scholar Rock Holding Corp

56.16
-0.3450-0.61%
Volume:109.61K
Turnover:6.19M
Market Cap:6.84B
PE:-16.71
High:56.80
Open:56.80
Low:55.90
Close:56.50
52wk High:58.49
52wk Low:27.07
Shares:121.79M
Float Shares:107.73M
Volume Ratio:2.22
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3601
EPS(LYR):-3.4845
ROE:-167.77%
ROA:-58.82%
PB:26.95
PE(LYR):-16.12

Loading ...

Scholar Rock (SRRK) Is Up 8.5% After De-Risking Apitegromab’s Global Filing Pathway - Has The Bull Case Changed?

Simply Wall St.
·
5 hours ago

Scholar Rock's Global Regulatory Path Further De-Risked, Wedbush Says

MT Newswires Live
·
Aug 22

Wedbush Adjusts Scholar Rock Price Target to $64 From $58, Maintains Outperform Rating

MT Newswires Live
·
Aug 22

Scholar Rock price target raised to $64 from $58 at Wedbush

TIPRANKS
·
Aug 21

Scholar Rock removes Catalent Indiana from apitegromab BLA under FDA guidance

TIPRANKS
·
Aug 21

Scholar Rock Holding Corporation - Prepared for U.S. Apitegromab Launch upon FDA Approval by Sept 30, 2026 Pdufa Date

THOMSON REUTERS
·
Aug 21

Scholar Rock Holding Corporation - Withdraws Apitegromab Maa in Europe; to Resubmit with Alternate Fill-Finish Facility

THOMSON REUTERS
·
Aug 21

Scholar Rock Holding Corporation - Pmda Agrees no Additional Clinical Studies Required; Scholar Rock to Submit Apitegromab Jnda by Ye 2026

THOMSON REUTERS
·
Aug 21

Scholar Rock Withdraws EU Apitegromab Filing After FDA Flags Catalent Indiana Plant with OAI Inspection Rating

Reuters
·
Aug 21

How Investors Are Reacting To Scholar Rock (SRRK) Dual Fill-Finish Readiness Amid Ongoing FDA Review

Simply Wall St.
·
Aug 15

Scholar Rock Grants Inducement Equity Awards for 51,947 Shares to 12 New Hires

Reuters
·
Aug 15

Scholar Rock Reports New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 15

Scholar Rock Holding Price Target Raised to $63.00/Share from $56.00 by JP Morgan

Dow Jones
·
Aug 13

Scholar Rock Holding Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 10

Update: Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date

MT Newswires Live
·
Aug 10

Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date

MT Newswires Live
·
Aug 08

Scholar Rock Holdings Pulls Novo Nordisk Facility from Drug Application After FDA Flag

Dow Jones
·
Aug 08

Scholar Rock to remove Catalent Indiana facility from apitegromab BLA

TIPRANKS
·
Aug 08

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)

TIPRANKS
·
Aug 08

Scholar Rock Drops Catalent Indiana from Apitegromab BLA After FDA Flags Site Inspection as OAI

Reuters
·
Aug 08